BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11284431)

  • 1. [Multicolor fluorescence in situ hybridization (mFISH].
    Michalová K; Zemanová Z; Brezinová J
    Cas Lek Cesk; 2001 Mar; 140(4):99-103. PubMed ID: 11284431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of complex chromosomal rearrangements in adult patients with MDS and AML by multicolor FISH.
    Babicka L; Ransdorfova S; Brezinova J; Zemanova Z; Sindelarova L; Siskova M; Maaloufova J; Cermak J; Michalova K
    Leuk Res; 2007 Jan; 31(1):39-47. PubMed ID: 16687173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Pavlistová L; Babická L; Housková L; Melichercíková J; Sisková M; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2007 Feb; 173(1):10-6. PubMed ID: 17284364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined spectral karyotyping, multicolor banding, and microarray comparative genomic hybridization analysis provides a detailed characterization of complex structural chromosomal rearrangements associated with gene amplification in the osteosarcoma cell line MG-63.
    Lim G; Karaskova J; Vukovic B; Bayani J; Beheshti B; Bernardini M; Squire JA; Zielenska M
    Cancer Genet Cytogenet; 2004 Sep; 153(2):158-64. PubMed ID: 15350306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicolor Karyotyping and Fluorescence In Situ Hybridization-Banding (MCB/mBAND).
    Liehr T; Othman MA; Rittscher K
    Methods Mol Biol; 2017; 1541():181-187. PubMed ID: 27910024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
    Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
    Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetics and fluorescence in-situ hybridization in detection of hematological malignancies.
    Frenny VJ; Antonella Z; Luisa A; Shah AD; Sheth JJ; Rocchi M
    Indian J Cancer; 2003; 40(4):135-9. PubMed ID: 14716109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of complex chromosomal aberrations in patients with myelodysplastic syndromes using multiplex fluorescence in situ hybridization combined with whole chromosome painting].
    Chen LJ; Li JY; Xiao B; Zhu Y; Liu Q; Pan JL; Qiu HR; Fan L; Zhang SJ; Lu RN; Xu W; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):635-9. PubMed ID: 18067073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH.
    Evers C; Beier M; Poelitz A; Hildebrandt B; Servan K; Drechsler M; Germing U; Royer HD; Royer-Pokora B
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1119-28. PubMed ID: 17823930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetic characterization of pancreas cancer cell lines reveals high complexity chromosomal alterations.
    Griffin CA; Morsberger L; Hawkins AL; Haddadin M; Patel A; Ried T; Schrock E; Perlman EJ; Jaffee E
    Cytogenet Genome Res; 2007; 118(2-4):148-56. PubMed ID: 18000365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three rearrangements of chromosome 5 in a patient with myelodysplastic syndrome: an atypical deletion 5q, a complex intrachromosomal rearrangement of chromosome 5, and a paracentric inversion of chromosome 5.
    Douet-Guilbert N; Basinko A; Eveillard JR; Morel F; Le Bris MJ; Guéganic N; Bovo C; Herry A; Berthou C; De Braekeleer M
    Cancer Genet Cytogenet; 2010 Dec; 203(2):303-8. PubMed ID: 21156249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicolor FISH methods in current clinical diagnostics.
    Liehr T; Weise A; Hamid AB; Fan X; Klein E; Aust N; Othman MA; Mrasek K; Kosyakova N
    Expert Rev Mol Diagn; 2013 Apr; 13(3):251-5. PubMed ID: 23570403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cytogenetic analysis of complex karyotypes with derivative chromosome der(1)t(1;5) found in two patients with myeloid leukemia.
    Melichercíková J; Brezinová J; Zemanová Z; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2007 Jul; 176(2):150-5. PubMed ID: 17656259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in situ hybridization (FISH) in cytogenetics of leukemia.
    Michalová K
    Folia Biol (Praha); 1996; 42(6):311-4. PubMed ID: 9158941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome analysis and molecular cytogenetic investigations of an epithelioid hemangioendothelioma.
    Tsarouha H; Kyriazoglou AI; Ribeiro FR; Teixeira MR; Agnantis N; Pandis N
    Cancer Genet Cytogenet; 2006 Sep; 169(2):164-8. PubMed ID: 16938576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiplex fluorescence in situ hybridization in detecting complex chromosomal aberrations in myelodysplastic syndromes].
    Xiao B; Li JY; Pan JL; Ma L; Qiu HR; Wu YF; Xue YQ
    Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):513-6. PubMed ID: 16468325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From "monocolor" karyotype to "multicolor" karyotype: applications of M-Fish in hematology and oncology].
    Jaffray JY; Giollant M; Perissel B; Vago P
    Bull Cancer; 2002 Feb; 89(2):174-80. PubMed ID: 11888857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Strategies to identify supernumerary chromosomal markers in constitutional cytogenetics].
    Douet-Guilbert N; Basinko A; Le Bris MJ; Herry A; Morel F; De Braekeleer M
    Pathol Biol (Paris); 2008 Sep; 56(6):362-7. PubMed ID: 18456432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging molecular cytogenetic technologies.
    Chang SS; Mark HF
    Cytobios; 1997; 90(360):7-22. PubMed ID: 9438335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional and molecular cytogenetic findings of myelodysplastic syndrome patients.
    Yilmaz Z; Sahin FI; Kizilkilic E; Karakus S; Boga C; Ozdogu H
    Clin Exp Med; 2005 Jul; 5(2):55-9. PubMed ID: 16096854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.